Articles On Thc Global Group (ASX:THC)

Summary The Australian cannabis industry welcomed TGA’s recent decision to down schedule cannabidiol. The regulatory body’s decision will come into effect from 1 February 2021, instead of 1 June 2021 set earlier. Most of the ASX-liste...

Marijuana companies – or “pot stocks” to those who prefer brevity – were all the rage back in late 2017 and early 2018. California, America’s most populous state and the fifth largest economy in the world, was legalising the recreational u...

A diversified global healthcare and pharmaceuticals company, THC Global Group Limited (ASX:THC) has provided strategic updates on its operations. The Company fully owns & operates complete commercial medicinal cannabis production facili...

The THC Global Group Ltd (ASX: THC) share price is climbing today, on news the company is fine tuning its strategy to meet potential demand in the medicinal cannabis industry. In early trade today, the THC Global share price surged up to 2...

The Elixinol Global Ltd (ASX: EXL) share price is on fire today, up more than 55% at the time of writing to 22 cents a share. The Elixinol share price closed at 14 cents a share last week, but opened this morning at 16 cents a share and ha...

Medicinal cannabis company THC Global (ASX: THC) has revealed several major strategic shifts to carve a bigger slice of the wider healthcare and pharmaceutical markets including a rebranding to reflect the move. As part of the rebrand, THC...

In afternoon trade on Wednesday the S&P/ASX 200 Index (ASX: XJO) is on form and on course to record a strong gain. The benchmark index is currently up 0.75% to 5,938.6 points. Four shares that have failed to follow the market higher to...

THC Global (ASX:THC) has been forced to justify its continued existence on the ASX after the troubled cannabis company delivered its half-year financial statements with an important proviso. Independent auditor K.S. Black & Co. delivere...

One of Australia's leading listed medicinal cannabis companies THC Global (ASX: THC) has today announced the shock immediate departure if its CEO Ken Charteris (pictured), who was instrumental in acquiring a manufacturing facility in Queens...

Money is coming in for marijuana companies, as Bod Australia (ASX:BOD) leads the total today with news of a $2.5m revenue June quarter. That last quarter of the financial year alone accounted for 42 per cent of total revenue booked for the...

On Stockhead today, how a ‘tired’ gold mine transformed shell company Bellevue into a $650m market darling, cobalt has stumbled this year but EV growth is expected to drive demand and prices and is this a new dawn for nickel? But first…   T...

THC Global Group (ASX: THC) has signed a 12-month supply and production deal with Australian “seed-to-patient” medical cannabis business Cannatrek to develop and manufacture Cannatrek-branded medicines on contract. Under the terms of the ag...

The first Australian-produced full-spectrum medicinal cannabidiol manufactured by diversified cannabis company THC Global (ASX: THC) has become available for prescription to Australian patients under the country’s Special Access Scheme. Mar...

Queensland medical marijuana group THC Global (ASX:THC) has started selling its products in Australia, with the first one available by prescription under the government’s Special Access Scheme (SAS). THC is one of several companies which an...

Cannabis producer THC Global (ASX: THC) will further diversify its business with a $3 million acquisition of clinic operator Tetra Health. Post-acquisition THC will gain access to Tetra's network of medical practitioners comprising more t...

THC Global Group (ASX: THC) will pay $3 million in shares and cash to acquire the Tetra Health network of clinics which provide access to legal medicinal cannabis. Tetra’s network comprises over 630 referring and prescribing physicians, as...

THC Global (ASX: THC) has set a firm date for when its Australian-made Canndeo branded medicinal cannabis medicines will be made available for prescription in Australia. The company’s chief executive officer Ken Charteris declared that THC...

There are ASX small caps addressing brain problems and stocks seeking to test cannabis for medicinal purposes and Impression Healthcare (ASX:IHL) is now doing both. This morning the company announced next quarter it would begin a clinical t...

Medicinal cannabis developer THC Global (ASX: THC) has updated the market with news that it has received an expanded commercial cultivation permit from the Australian Office of Drug Control (ODC). THC is the first ASX-listed company to full...

The THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and is zooming higher on Tuesday morning. At the time of writing the cannabis company’s shares are up 11% to 34.5 cents. Why was the THC Global share price...

THC Global (THC) will soon begin the international supply of medicines in Australia and internationally Under the Canndeo brand, THC’s medicines range will be launched by the end of this quarter, offering prescribers a higher quality, low...

Eleven small caps were snared in the corporate cop’s enquiries into annual reports last year, leading it rather than the companies involved to inform the market about asset write downs. ASIC reviewed 2019 annual reports from 200 companies,...

The THC Global Group Ltd (ASX: THC) share price has just finished the week on a high. On Friday the medicinal cannabis company’s shares climbed as much as 4% higher before ending the day with a gain of 1.5% to 38 cents. Why did the THC Glo...

The survival of the southern Western Australia town of Collie is inextricably linked to the fortunes of the coal mines it was built on. But with the dire situation in coal escalating for the tiny town, cannabis could be its saving grace. Co...

Special Report: The deal with THC Global (ASX:THC) is evidence of the demand for MGC products in the broader medicinal cannabis market. Over the last 6 months, MGC Pharma (ASX:MXC) has established some good traction in the market with its...

The S&P/ASX 200 index has run out of steam on Tuesday and looks set to end its winning run. In afternoon trade the benchmark index is down 0.5% to 7,045.4 points. Four shares that have not let that hold them back today are listed below...

THC Global Group (ASX: THC) is poised to commence commercial-scale production of medicinal cannabis after its pharmaceutical bio-floral extraction facility in Queensland was granted a manufacturing licence from the Australian Therapeutic Go...

The THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and rocketed higher. In morning trade the cannabis company’s shares are up 19% to 46 cents. Why is the THC Global share price rocketing higher? Investors ha...

Hot on the heels of a new partnership with MGC Pharma (ASX: MXC) THC Global (ASX: THC) has received a licence to manufacture therapeutic goods at its state-of-the-art facility in Southport. The licence, known as a GMP Licence, is the fina...

THC Global (THC) has signed a supply agreement with MGC Pharmaceuticals (MXC) for its medicinal cannabis products THC’s Canndeo branded medicinal cannabis product range will be launching in Q1 2020 The agreement has a minimum term of 18...

Medicinal cannabis companies THC Global (ASX: THC) and Europe-based, Australian-listed MGC Pharma (ASX: MXC) have signed a new supply deal this morning. The agreement will see MGC Pharma provide THC Global with an "immediate" source of me...

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is starting the week on a high. In morning trade the cannabis company’s shares are up 3% to 3.8%. They were up as much as 8% at one stage. Why is the MCG Pharma share price on a high? Inve...

Cann Group’s (ASX: CAN) manufacturer has started making cannabis resin from the company’s plants, and it should be ready for sale by March. The resin needs to be tested for stability before being sold as oil and as an active pharmaceutical...

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

There is a lot of optimism surrounding the outlook for the multi-billion-dollar global cannabis industry, which may not be still evident from the share prices but increasing number of nations are now introducing proper legal framework to ba...

Cannabis industry is booming at a rapid pace, with several governments creating opportunities for investors by legalising recreational and medicinal cannabis. With increasing legalisation of cannabis, number of investors and entrepreneurs j...

Cann Global (ASX:CGB) has become the second small cap to enter the African cannabis market. It is a market that is estimated to reach $7.1 billion by 2023 although is only legal in three countries including South Africa, Zimbabwe and Lesoth...

There’s no doubt 2019 has been a difficult year for ASX cannabis shares. Many of the ASX-listed producers have struggled to climb higher and, in many cases, have experienced heavy losses. So is there hope for long-term investors in the Aus...

A significant progress has been seen in Cannabis industry at a global scale, a sector that has witnessed traction and speculation at the same time. Once, a topic of taboo, cannabis is one of the most debated topics worldwide currently.  Can...

As the market players are aware, the stock markets in Australia is generally influenced by the broader performance of Australian economy as well as by the health of global economy. A rise in the economic uncertainties might negatively impac...

Legal weed could be a thing in New Zealand next year, but not before the populous decides whether it gets the go-ahead. Kiwis are set to participate in a 2020 cannabis referendum, and the government has just released a draft of what they’ll...

Australia-based THC Global Group Limited (ASX: THC) operates under a ‘Farm to Pharma’ pharmaceutical model (Vertically Integrated) and now holds all 3 Key Cannabis Licences, through its domestic medicinal cannabis subsidiaries THC Pharma an...

In afternoon trade the S&P/ASX 200 index looks set to record its second consecutive sizeable decline. At the time of writing the benchmark index is down 1.6% to 6,603.8 points. Four shares that have not let that hold them back today ar...

Pot stock THC Global (ASX:THC) is in business at Southport, the largest medicinal cannabis production hub in the southern hemisphere. The company announced the release of its completed Canndeo line of cannabis medicines, cultivated using ma...

The THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and surged higher. At the time of writing the cannabis company’s shares are up 11% to 41 cents. Why were THC Global’s shares in a trading halt? THC Global r...

After several years of planning and navigating an exhaustive path of obtaining regulatory approvals, medicinal cannabis developer THC Global (ASX: THC) has finally completed its first round of “farm-to-pharma” cannabis processing. The compa...

The Elixinol Global Ltd (ASX: EXL) share price has fallen 6.31% lower this morning after the Aussie cannabis group sold its Japanese operations yesterday.  What did Elixinol announce yesterday? In an after-market update, Elixinol confirmed...

Cannabis remains to be a subject of high speculation across the globe, even though significant advancement has been made in this field. A topic of taboo once, cannabis currently is one of the most discussed business opportunities globally,...

In the year 2019, marijuana stocks were among the hot picks for investors, despite the general market impulsiveness, strong competition and economic pressures. Recently, a green signal has been given to a bill legalising marijuana on the st...

ASX cannabis stock THC Global Group Ltd (ASX: THC) has seen its share price surge higher in today’s trade. The THC share price is up 3.66% at the time of writing to $0.42 per share as it recovers from Monday’s declines. So, what’s driving...